Filing Details
- Accession Number:
- 0001209191-17-031120
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-09 20:39:29
- Reporting Period:
- 2017-05-05
- Filing Date:
- 2017-05-09
- Accepted Time:
- 2017-05-09 20:39:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1180262 | Herbalife Ltd. | HLF | Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1504597 | Bosco Shin-Shing Chiu | 800 W. Olympic Boulevard, Suite 406 Los Angeles CA 90015 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-05-05 | 5,000 | $6.82 | 5,000 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-05-05 | 492 | $69.40 | 4,508 | No | 4 | D | Direct | |
Common Stock | Disposition | 2017-05-05 | 1,695 | $69.40 | 2,813 | No | 4 | F | Direct | |
Common Stock | Disposition | 2017-05-09 | 2,813 | $71.90 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | D | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Appreciation Rights | Disposition | 2017-05-05 | 5,000 | $0.00 | 5,000 | $6.82 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-02-27 | 2019-02-27 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 17, 2016.
- The reporting person forfeited 492 shares of common stock underlying the SARS in payment of the exercise price and 1,695 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 5, 2017 of $69.40.